Patents by Inventor William Kerns

William Kerns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240293405
    Abstract: The invention generally relates to pharmaceuticals and therapeutic methods. More particularly, the invention provides small molecule EGFR inhibitors (e.g., EGFR tyrosine kinase inhibitor compounds) and pharmaceutical compositions thereof, as well as methods of their use in treating various diseases and conditions, such as cancers of the central nervous system (e.g., primary and metastatic brain cancers) and lung cancers.
    Type: Application
    Filed: June 22, 2022
    Publication date: September 5, 2024
    Inventors: Jean J. Zhao, William Kerns
  • Publication number: 20050264001
    Abstract: A system and method using reporter elements provides retrospective identification of articles. An article is marked with reporter elements such that the mark has a characteristic spectral response when exposed to energy stimulation. To verify the authenticity of the article, a reader scans the mark containing the reporter elements and obtains a spectral signature. The reader then compares the detected signature to the characteristic signature to determine the authenticity or identity of the marked article.
    Type: Application
    Filed: August 1, 2005
    Publication date: December 1, 2005
    Inventors: William Kerns, Brian Brogger
  • Publication number: 20050215517
    Abstract: The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
    Type: Application
    Filed: December 13, 2004
    Publication date: September 29, 2005
    Inventors: Daniel Rossignol, Melvyn Lynn, William Kerns
  • Publication number: 20050101560
    Abstract: A method for treating an individual with IB-MECA to achieve a therapeutic effect is provided. The method comprises administering to the individual a dose of IB-MECA in an amount and for a time such so as to achieve a maximal blood level of less than about 1.60 nM.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 12, 2005
    Applicant: CAN-FITE BIOPHARMA LTD.
    Inventors: Steve Warrington, Michael Silverman, William Kerns, Pnina Fishman, Ilan Cohn
  • Publication number: 20010049101
    Abstract: A small micro-label with a machine-readable indicia is used to react with and identify analytes in a multiplex reaction with biologic molecules.
    Type: Application
    Filed: February 22, 2001
    Publication date: December 6, 2001
    Inventors: Brian Brogger, Justin Esterberg, William Kerns